The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - Epcoritamab Global Council
Consulting or Advisory Role - Abbvie; BeiGene; Bristol-Myers Squibb; Celgene; Genmab; Kite/Gilead; Roche
Speakers' Bureau - Abbvie; Celgene
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CellCentric (Inst); Genmab (Inst); Janssen (Inst); Kite/Gilead (Inst); MorphoSys (Inst); MSD (Inst); Nurix (Inst); Regeneron (Inst); Roche (Inst); Step Pharma (Inst); Viracta Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene
Epcoritamab + R2 regimen and responses in high-risk follicular lymphoma, regardless of POD24 status.
 
Reid Merryman
Consulting or Advisory Role - Adaptive Biotechnologies; Bristol-Myers Squibb/Medarex; Genmab
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Genmab (Inst); Merck (Inst)
 
David Belada
Consulting or Advisory Role - Gilead Sciences; Janssen-Cilag; MorphoSys; Roche; Takeda
Research Funding - Dr. Reddy's (Inst); Genmab (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); MorphoSys (Inst); Pharmacyclics (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche; Takeda
 
Anna Sureda
Honoraria - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Novartis; Takeda
Speakers' Bureau - Takeda
Travel, Accommodations, Expenses - Kite/Gilead
Other Relationship - Celgene; Gilead Sciences; Roche; Sanofi; Takeda
 
Sirpa Leppä
Honoraria - Gilead Sciences; Incyte; Novartis
Consulting or Advisory Role - BeiGene; Gilead Sciences; Incyte; Novartis; Orion Clinical; Pfizer; Roche; SOBI
Research Funding - Bayer (Inst); Celgene (Inst); Genmab (Inst); Hutchison MediPharma (Inst); Novartis (Inst); Roche (Inst)
 
Joost S.P. Vermaat
Consulting or Advisory Role - Secura Bio
 
Harald Holte
Consulting or Advisory Role - Gilead Sciences; Incyte; Novartis; Roche; Takeda
Research Funding - Incyte
Other Relationship - Genmab; Nordic Nanovector
 
Martin Hutchings
Consulting or Advisory Role - Abbvie; Genmab; Janssen; Roche; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Genmab (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Pieternella Lugtenburg
Consulting or Advisory Role - Abbvie; Celgene; Genmab; Incyte; Regeneron; Roche/Genentech; Takeda; Y-mAbs Therapeutics
Research Funding - SERVIER (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Celgene
 
Sven de Vos
No Relationships to Disclose
 
Pau Abrisqueta
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Janssen
Speakers' Bureau - Abbvie; AstraZeneca; Bristol-Myers Squibb; Janssen
 
Marcel Nijland
Consulting or Advisory Role - Abbvie
Research Funding - Nordic Nanovector; Takeda
 
Jacob Haaber Christensen
No Relationships to Disclose
 
Björn E. Wahlin
Stock and Other Ownership Interests - Genmab
Research Funding - Roche
 
Kim M. Linton
No Relationships to Disclose
 
Liwei Wang
Employment - Genmab
 
Aqeel Abbas
Employment - Genmab
 
Ali Rana
Employment - Genmab
 
Syed Quadri
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Lorenzo Falchi
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Genmab; Roche/Genentech; Seagen
Research Funding - Genentech; Genmab; Roche
Travel, Accommodations, Expenses - Genmab